Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 25, 2023

SELL
$225.79 - $275.2 $4,741 - $5,779
-21 Reduced 1.65%
1,254 $303,000
Q4 2022

Jan 25, 2023

BUY
$229.03 - $291.01 $15,345 - $19,497
67 Added 5.55%
1,275 $0
Q3 2022

Oct 24, 2022

BUY
$224.46 - $253.15 $12,569 - $14,176
56 Added 4.86%
1,208 $272,000
Q2 2022

Aug 05, 2022

BUY
$230.71 - $256.74 $7,613 - $8,472
33 Added 2.95%
1,152 $280,000
Q1 2022

May 13, 2022

BUY
$219.27 - $242.57 $8,332 - $9,217
38 Added 3.52%
1,119 $271,000
Q4 2021

Feb 14, 2022

SELL
$198.88 - $227.6 $15,711 - $17,980
-79 Reduced 6.81%
1,081 $243,000
Q3 2021

Oct 29, 2021

SELL
$212.27 - $248.7 $65,591 - $76,848
-309 Reduced 21.03%
1,160 $247,000
Q2 2021

Jul 29, 2021

BUY
$233.58 - $259.14 $73,344 - $81,369
314 Added 27.19%
1,469 $358,000
Q1 2021

May 06, 2021

BUY
$221.91 - $258.6 $6,435 - $7,499
29 Added 2.58%
1,155 $287,000
Q4 2020

Feb 04, 2021

BUY
$216.38 - $257.67 $649 - $773
3 Added 0.27%
1,126 $259,000
Q3 2020

Nov 10, 2020

BUY
$234.65 - $260.95 $7,274 - $8,089
31 Added 2.84%
1,123 $285,000
Q2 2020

Aug 10, 2020

SELL
$197.81 - $242.74 $10,483 - $12,865
-53 Reduced 4.63%
1,092 $258,000
Q1 2020

May 01, 2020

BUY
$182.24 - $241.7 $6,013 - $7,976
33 Added 2.97%
1,145 $232,000
Q4 2019

Feb 12, 2020

SELL
$189.21 - $243.2 $12,298 - $15,808
-65 Reduced 5.52%
1,112 $268,000
Q3 2019

Nov 12, 2019

BUY
$174.11 - $208.62 $13,406 - $16,063
77 Added 7.0%
1,177 $228,000
Q2 2019

Jul 26, 2019

SELL
$166.7 - $195.41 $666 - $781
-4 Reduced 0.36%
1,100 $203,000
Q1 2019

May 13, 2019

SELL
$180.87 - $203.88 $1,627 - $1,834
-9 Reduced 0.81%
1,104 $210,000
Q4 2018

Feb 11, 2019

BUY
$178.4 - $208.25 $535 - $624
3 Added 0.27%
1,113 $217,000
Q3 2018

Oct 31, 2018

SELL
$185.29 - $208.89 $9,449 - $10,653
-51 Reduced 4.39%
1,110 $230,000
Q2 2018

Aug 10, 2018

SELL
$166.05 - $186.51 $1,992 - $2,238
-12 Reduced 1.02%
1,161 $214,000
Q1 2018

May 01, 2018

BUY
$169.43 - $198.0 $198,741 - $232,254
1,173 New
1,173 $200,000
Q4 2017

Feb 01, 2018

SELL
$168.79 - $188.59 $185,500 - $207,260
-1,099 Closed
0 $0
Q3 2017

Nov 02, 2017

BUY
$167.29 - $191.0 $183,851 - $209,909
1,099
1,099 $205,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Halbert Hargrove Global Advisors, LLC Portfolio

Follow Halbert Hargrove Global Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Halbert Hargrove Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Halbert Hargrove Global Advisors, LLC with notifications on news.